Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.

Effect of Pravastatin on Outcomes after Cardiac Transplantation

Open access

Abstract

BACKGROUND: Hypercholesterolemia is common after cardiac transplantation and may contribute to the development of coronary vasculopathy. Pravastatin, a 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitor, has been shown to be effective and safe in lowering cholesterol levels after cardiac transplantation. Cell-culture studies using inhibitors of HMG-CoA reductase have suggested an immunosuppressive effect. METHODS: Early after transplantation, we randomly assigned consecutive patients to receive either pravastatin (47 patients) or no HMG-CoA reductase inhibitor (50 patients). RESULTS: Twelve months after transplantation, the pravastatin group had lower mean (+/- SD) cholesterol levels than the control group (193 +/- 36 vs. 248 +/- 49 mg per deciliter, P < 0.001), less frequent cardiac rejection accompanied by hemodynamic compromise (3 vs. 14 patients, P = 0.005), better survival (94 percent vs. 78 percent, P = 0.025), and a lower incidence of coronary vasculopathy in the transplant as determined by angiography and at autopsy (3 vs. 10 patients, P = 0.049). There was no difference between the two groups in the incidence of mild or moderate episodes of cardiac rejection. In a subgroup of study patients, intracoronary ultrasound measurements at base line and one year after transplantation showed less progression in the pravastatin group in maximal intimal thickness (0.11 +/- 0.09 mm, vs. 0.23 +/- 0.16 mm in the control group; P = 0.002) and in the intimal index (0.05 +/- 0.03 vs. 0.10 +/- 0.10, P = 0.031). In a subgroup of patients, the cytotoxicity of natural killer cells was lower in the pravastatin group than in the control group (9.8 percent vs. 22.2 percent specific lysis, P = 0.014). CONCLUSIONS: After cardiac transplantation, pravastatin had beneficial effects on cholesterol levels, the incidence of rejection causing hemodynamic compromise, one-year survival, and the incidence of coronary vasculopathy.

Overview

Integrity signals

Registry

Crossref · 10.1056/nejm199509073331003

Cites

23 of 23 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 22 references

Research works printed but not linked: 7

  1. Eich D, 1991, J Heart Lung Transplant, 10, 45
  2. Blankenhorn DH, 1993, West J Med, 159, 172
  3. Meiser BM, 1993, Transplant Proc, 25, 2077
  4. Kobashigawa JA, 1990, Circulation, 82, IV
  5. Ensley RD, 1991, Transplant Proc, 23, 1130
  6. Hammond EH, 1992, J Heart Lung Transplant, 11, S111
  7. Lin H, 1994, J Heart Lung Transplant, 13, 824

Cited by

See all 1,301

Metadata

Authors
Kobashigawa, J. A., Katznelson, S., Laks, H., Johnson, J. A., Yeatman, L., Wang, X. M., Chia, D., Terasaki, P. I., Sabad, A., Cogert, G. A., Trosian, K., Hamilton, M. A., Moriguchi, J. D., Kawata, N., Hage, A., Drinkwater, D. C., & Stevenson, L. W.
Affiliations
  • University of California, Los Angeles (US)
  • Brigham and Women's Hospital (US)
Venue
New England Journal of Medicine
Published
1995-09-07
Volume
333
Issue
10
Pages
621-627
ISSN
  • 0028-4793 (ISSN-L)
  • 1533-4406
OpenAlex
W2338977280
Cited by
1,301
References
22
Citations by year
2026: 11 · 2025: 18 · 2024: 18 · 2023: 15 · 2022: 14 · 2021: 19 · 2020: 27 · 2019: 23 · 2018: 32 · 2017: 28 · 2016: 28 · 2015: 25 · 2014: 49 · 2013: 29 · 2012: 31
FWCI
47.54
Type
journal article
Language
en
Open access
Locations
  • New England Journal of Medicine (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Surgery › Transplantation: Methods and Outcomes
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
  • Health Sciences › Medicine › Surgery › Cardiac and Coronary Surgery Techniques
Keywords
pravastatin, heart transplantation, statins, hypercholesterolemia, coronary vasculopathy, immunosuppression, cardiac rejection, survival, intimal thickening, NK cell cytotoxicity, cholesterol lowering
MeSH terms
Cholesterol, Coronary Disease, Coronary Vessels, Cytotoxicity, Immunologic, Female, Graft Rejection, Humans, Hypercholesterolemia, Killer Cells, Natural, Male, Middle Aged, Prospective Studies, Incidence, Survival Rate, Heart Transplantation, Pravastatin, Ultrasonography, Interventional

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Effect of Pravastatin on Outcomes after Cardiac Transplantation. https://app.cochat.ai/papers/10.1056/nejm199509073331003
The paper
Kobashigawa, J. A., Katznelson, S., Laks, H., Johnson, J. A., Yeatman, L., Wang, X. M., Chia, D., Terasaki, P. I., Sabad, A., Cogert, G. A., Trosian, K., Hamilton, M. A., Moriguchi, J. D., Kawata, N., Hage, A., Drinkwater, D. C., & Stevenson, L. W. (1995). Effect of Pravastatin on Outcomes after Cardiac Transplantation. New England Journal of Medicine. https://doi.org/10.1056/nejm199509073331003

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.